These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 23249382)

  • 1. Determination of the differential expression of mitochondrial long non-coding RNAs as a noninvasive diagnosis of bladder cancer.
    Rivas A; Burzio V; Landerer E; Borgna V; Gatica S; Ávila R; López C; Villota C; de la Fuente R; Echenique J; Burzio LO; Villegas J
    BMC Urol; 2012 Dec; 12():37. PubMed ID: 23249382
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Down-regulation of the antisense mitochondrial non-coding RNAs (ncRNAs) is a unique vulnerability of cancer cells and a potential target for cancer therapy.
    Vidaurre S; Fitzpatrick C; Burzio VA; Briones M; Villota C; Villegas J; Echenique J; Oliveira-Cruz L; Araya M; Borgna V; Socías T; Lopez C; Avila R; Burzio LO
    J Biol Chem; 2014 Sep; 289(39):27182-27198. PubMed ID: 25100722
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Noninvasive detection and prediction of bladder cancer by fluorescence in situ hybridization analysis of exfoliated urothelial cells in voided urine.
    Ishiwata S; Takahashi S; Homma Y; Tanaka Y; Kameyama S; Hosaka Y; Kitamura T
    Urology; 2001 Apr; 57(4):811-5. PubMed ID: 11306420
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expression of mitochondrial non-coding RNAs (ncRNAs) is modulated by high risk human papillomavirus (HPV) oncogenes.
    Villota C; Campos A; Vidaurre S; Oliveira-Cruz L; Boccardo E; Burzio VA; Varas M; Villegas J; Villa LL; Valenzuela PD; Socías M; Roberts S; Burzio LO
    J Biol Chem; 2012 Jun; 287(25):21303-15. PubMed ID: 22539350
    [TBL] [Abstract][Full Text] [Related]  

  • 5. HPV-18 E2 protein downregulates antisense noncoding mitochondrial RNA-2, delaying replicative senescence of human keratinocytes.
    Villota C; Varas-Godoy M; Jeldes E; Campos A; Villegas J; Borgna V; Burzio LO; Burzio VA
    Aging (Albany NY); 2018 Dec; 11(1):33-47. PubMed ID: 30595560
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nuclear localization of the mitochondrial ncRNAs in normal and cancer cells.
    Landerer E; Villegas J; Burzio VA; Oliveira L; Villota C; Lopez C; Restovic F; Martinez R; Castillo O; Burzio LO
    Cell Oncol (Dordr); 2011 Aug; 34(4):297-305. PubMed ID: 21347712
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Oncoprotein DEK as a tissue and urinary biomarker for bladder cancer.
    Datta A; Adelson ME; Mogilevkin Y; Mordechai E; Sidi AA; Trama JP
    BMC Cancer; 2011 Jun; 11():234. PubMed ID: 21663673
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fluorescence In Situ Hybridization in Urine Samples (UroVysion Kit).
    Bravaccini S
    Methods Mol Biol; 2021; 2292():35-48. PubMed ID: 33651350
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Quantitation of Aurora kinase A gene copy number in urine sediments and bladder cancer detection.
    Park HS; Park WS; Bondaruk J; Tanaka N; Katayama H; Lee S; Spiess PE; Steinberg JR; Wang Z; Katz RL; Dinney C; Elias KJ; Lotan Y; Naeem RC; Baggerly K; Sen S; Grossman HB; Czerniak B
    J Natl Cancer Inst; 2008 Oct; 100(19):1401-11. PubMed ID: 18812553
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vivo knockdown of antisense non-coding mitochondrial RNAs by a lentiviral-encoded shRNA inhibits melanoma tumor growth and lung colonization.
    Varas-Godoy M; Lladser A; Farfan N; Villota C; Villegas J; Tapia JC; Burzio LO; Burzio VA; Valenzuela PDT
    Pigment Cell Melanoma Res; 2018 Jan; 31(1):64-72. PubMed ID: 28707763
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Detection of Bladder Cancer in Urine Sediments by a Novel Multicolor Fluorescence In Situ Hybridization (Quartet) Test.
    Zhang S; Wang Y; Bondaruk J; Majewski T; Yao H; Lee S; Lee JG; Cogdell D; Lotan Y; Dinney C; Wei P; Baggerly K; Czerniak B
    Eur Urol Focus; 2019 Jul; 5(4):664-675. PubMed ID: 29428551
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fluorescence in situ hybridization performed on exfoliated urothelial cells in patients with transitional cell carcinoma of the bladder.
    Degtyar P; Neulander E; Zirkin H; Yusim I; Douvdevani A; Mermershtain W; Kaneti J; Manor E
    Urology; 2004 Feb; 63(2):398-401. PubMed ID: 14972510
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Noninvasive detection of alterations in chromosome numbers in urinary bladder cancer cells, using fluorescence in situ hybridization.
    Okamura T; Umemoto Y; Yasui T; Saiki S; Kuroda H; Kotoh S; Kamizaki H
    Int J Clin Oncol; 2004 Oct; 9(5):373-7. PubMed ID: 15549587
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [The diagnostic value of microsatellite LOH analysis and the prognostic relevance of angiogenic gene expression in urinary bladder cancer].
    Szarvas T
    Magy Onkol; 2009 Dec; 53(4):385-9. PubMed ID: 20071311
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Utility of a multiprobe fluorescence in situ hybridization assay in the detection of superficial urothelial bladder cancer.
    Marín-Aguilera M; Mengual L; Ribal MJ; Burset M; Arce Y; Ars E; Oliver A; Villavicencio H; Algaba F; Alcaraz A
    Cancer Genet Cytogenet; 2007 Mar; 173(2):131-5. PubMed ID: 17321328
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of the telomeric repeat amplification protocol (TRAP) assay for telomerase as a diagnostic modality in recurrent bladder cancer.
    Dalbagni G; Han W; Zhang ZF; Cordon-Cardo C; Saigo P; Fair WR; Herr H; Kim N; Moore MA
    Clin Cancer Res; 1997 Sep; 3(9):1593-8. PubMed ID: 9815848
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Detection of telomerase activity in exfoliated cells in urine from patients with bladder cancer.
    Kinoshita H; Ogawa O; Kakehi Y; Mishina M; Mitsumori K; Itoh N; Yamada H; Terachi T; Yoshida O
    J Natl Cancer Inst; 1997 May; 89(10):724-30. PubMed ID: 9168188
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Multiprobe FISH for enhanced detection of bladder cancer in voided urine specimens and bladder washings.
    Bubendorf L; Grilli B; Sauter G; Mihatsch MJ; Gasser TC; Dalquen P
    Am J Clin Pathol; 2001 Jul; 116(1):79-86. PubMed ID: 11447756
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Detection of bladder cancer from the urine using fluorescence in situ hybridization technique.
    Riesz P; Lotz G; Páska C; Szendrôi A; Majoros A; Németh Z; Törzsök P; Szarvas T; Kovalszky I; Schaff Z; Romics I; Kiss A
    Pathol Oncol Res; 2007; 13(3):187-94. PubMed ID: 17922047
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical utility of a multiprobe FISH assay in voided urine specimens for the detection of bladder cancer and its recurrences, compared with urinary cytology.
    Placer J; Espinet B; Salido M; Solé F; Gelabert-Mas A
    Eur Urol; 2002 Dec; 42(6):547-52. PubMed ID: 12477649
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.